{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:50:16Z","timestamp":1777589416876,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.apsb.2020.12.019","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T02:07:05Z","timestamp":1610244425000},"page":"1667-1675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5586-2906","authenticated-orcid":false,"given":"David","family":"Dahlgren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Olander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Sj\u00f6blom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8962-2815","authenticated-orcid":false,"given":"Mikael","family":"Hedeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Lennern\u00e4s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2020.12.019_bib1","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1021\/acs.molpharmaceut.6b00515","article-title":"Regional intestinal permeability in dogs: biopharmaceutical aspects for development of oral modified-release dosage forms","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3390\/pharmaceutics10040263","article-title":"A comprehensive map of FDA-approved pharmaceutical products","volume":"10","author":"Zhong","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2020.12.019_bib3","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1023\/A:1012144232666","article-title":"Rat jejunal permeability and metabolism of \u03bc-selective tetrapeptides in gastrointestinal fluids from humans and rats","volume":"14","author":"Krondahl","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2020.12.019_bib4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/mp500809f","article-title":"Toward oral delivery of biopharmaceuticals: an assessment of the gastrointestinal stability of 17 peptide drugs","volume":"12","author":"Wang","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-3565(25)10613-7","article-title":"Gastrointestinal absorption of peptide drug: quantitative evaluation of the degradation and the permeation of metkephamid in rat small intestine","volume":"274","author":"Taki","year":"1995","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.apsb.2020.12.019_bib6","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","article-title":"Therapeutic peptides: historical perspectives, current development trends, and future directions","volume":"26","author":"Lau","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.apsb.2020.12.019_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsps.2014.06.004","article-title":"A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives","volume":"24","author":"Muheem","year":"2016","journal-title":"Saudi Pharmaceut J"},{"key":"10.1016\/j.apsb.2020.12.019_bib8","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3390\/ijms20102383","article-title":"A comprehensive review on current advances in peptide drug development and design","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2020.12.019_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/ja508766b","article-title":"Cell-permeable cyclic peptides from synthetic libraries inspired by natural products","volume":"137","author":"Hewitt","year":"2015","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2020.12.019_bib10","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1021\/acs.molpharmaceut.8b00466","article-title":"Enhancing oral bioavailability of cyclic RGD hexa-peptides by the lipophilic prodrug charge masking approach: redirection of peptide intestinal permeability from a paracellular to transcellular pathway","volume":"15","author":"Schumacher-Klinger","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2020.05.007","article-title":"Systemic delivery of peptides by the oral route: formulation and medicinal chemistry approaches","volume":"157","author":"Brayden","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2020.12.019_bib12","first-page":"1","article-title":"Advances in oral peptide therapeutics","author":"Drucker","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2020.12.019_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejps.2015.06.018","article-title":"Stability of peptide drugs in the colon","volume":"78","author":"Wang","year":"2015","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.apsb.2020.12.019_bib14","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejpb.2019.07.013","article-title":"Intestinal absorption-modifying excipients: a current update on preclinical in\u00a0vivo evaluations","volume":"142","author":"Dahlgren","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2015.06.003","article-title":"Rational design of agents to transiently increase paracellular permeability","volume":"210","author":"Park","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.12.019_bib16","doi-asserted-by":"crossref","first-page":"eaar7047","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2020.12.019_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/pharmaceutics12020099","article-title":"The in\u00a0vivo effect of transcellular permeation enhancers on the intestinal permeability of two peptide drugs enalaprilat and hexarelin","volume":"12","author":"Dahlgren","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2020.12.019_bib18","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.molpharmaceut.7b00353","article-title":"Preclinical effect of absorption modifying excipients on rat intestinal transport of five model compounds and the intestinal barrier marker 51Cr-EDTA","volume":"14","author":"Dahlgren","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.05.029","article-title":"The effects of three absorption-modifying critical excipients on the in\u00a0vivo intestinal absorption of six model compounds in rats and dogs","volume":"547","author":"Dahlgren","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/pharmaceutics12030242","article-title":"Regional intestinal drug permeability and effects of permeation enhancers in rat","volume":"12","author":"Dahlgren","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2020.12.019_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1748-1716.2006.01649.x","article-title":"Modulation of mucosal permeability by vasoactive intestinal peptide or lidocaine affects the adjustment of luminal hypotonicity in rat duodenum","volume":"189","author":"Nylander","year":"2007","journal-title":"Acta Physiol"},{"key":"10.1016\/j.apsb.2020.12.019_bib22","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1021\/jm9810102","article-title":"Correlation of human jejunal permeability (in\u00a0vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach","volume":"41","author":"Winiwarter","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2020.12.019_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.2042-7158.1998.tb06187.x","article-title":"The effect of a drug-delivery system consisting of soybean phosphatidyl choline and medium-chain monoacylglycerol on the intestinal permeability of hexarelin in the rat","volume":"50","author":"Fagerholm","year":"1998","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.apsb.2020.12.019_bib24","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1211\/0022357011776540","article-title":"Hexarelin-evaluation of factors influencing oral bioavailability and\u00a0ways to improve absorption","volume":"53","author":"Westberg","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.apsb.2020.12.019_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejpb.2019.06.011","article-title":"Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model","volume":"142","author":"Dahlgren","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejpb.2018.09.001","article-title":"Time-dependent effects on small intestinal transport by absorption-modifying excipients","volume":"132","author":"Dahlgren","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib27","doi-asserted-by":"crossref","first-page":"G653","DOI":"10.1152\/ajpgi.1989.257.4.G653","article-title":"Effects of hydrochloric acid on duodenal and jejunal mucosal permeability in the rat","volume":"257","author":"Nylander","year":"1989","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2020.12.019_bib28","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/mp500834v","article-title":"Human in\u00a0vivo regional intestinal permeability: quantitation using site-specific drug absorption data","volume":"12","author":"Sj\u00f6gren","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2018.07.057","article-title":"Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in\u00a0vivo model for small intestinal transport","volume":"549","author":"Dahlgren","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11095-017-2331-z","article-title":"Closed-loop doluisio (colon, small intestine) and single-pass intestinal perfusion (colon, jejunum) in rat\u2014biophysical model and predictions based on Caco-2","volume":"35","author":"Lozoya-Agullo","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2020.12.019_bib31","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2147\/IJN.S194934","article-title":"Formulation design, characterization, and in\u00a0vitro and in\u00a0vivo evaluation of nanostructured lipid carriers containing a bile salt for oral delivery of gypenosides","volume":"14","author":"Yang","year":"2019","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.apsb.2020.12.019_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ejpb.2019.07.012","article-title":"Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions","volume":"142","author":"Roos","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.apsb.2020.12.019_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jconrel.2018.08.032","article-title":"Oral peptide delivery: translational challenges due to physiological effects","volume":"287","author":"Tyagi","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.apsb.2020.12.019_bib34","first-page":"41","article-title":"Semaglutide tablets (Rybelsus)","author":"Elliott","year":"2019","journal-title":"Intern Med Alert"},{"key":"10.1016\/j.apsb.2020.12.019_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2265.1993.tb00990.x","article-title":"Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers","volume":"38","author":"Fjellestad-Paulsen","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.apsb.2020.12.019_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12020-011-9492-z","article-title":"Desmopressin duration of antidiuretic action in patients with central diabetes insipidus","volume":"40","author":"Juul","year":"2011","journal-title":"Endocrine"},{"key":"10.1016\/j.apsb.2020.12.019_bib37","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s40262-017-0528-2","article-title":"Pharmacokinetics and tolerability of a single dose of semaglutide, a human glucagon-like peptide-1 analog, in subjects with and without renal impairment","volume":"56","author":"Marbury","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.apsb.2020.12.019_bib38","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1016\/j.xphs.2019.04.022","article-title":"Quantifying the value of orally delivered biologic therapies: a cost-effectiveness analysis of oral semaglutide","volume":"108","author":"Abramson","year":"2019","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.apsb.2020.12.019_bib39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.addr.2016.06.005","article-title":"Intestinal permeation enhancers for oral peptide delivery","volume":"106","author":"Maher","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2020.12.019_bib40","doi-asserted-by":"crossref","first-page":"a029181","DOI":"10.1101\/cshperspect.a029181","article-title":"Cell\u2013cell junctions organize structural and signaling networks","volume":"10","author":"Garcia","year":"2018","journal-title":"Cold Spr Harb Perspect Biol"},{"key":"10.1016\/j.apsb.2020.12.019_bib41","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.bbamem.2015.12.014","article-title":"Molecular simulation of nonfacilitated membrane permeation","volume":"1858","author":"Awoonor-Williams","year":"2016","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10.1016\/j.apsb.2020.12.019_bib42","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1023\/A:1012160102740","article-title":"Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement","volume":"14","author":"Schipper","year":"1997","journal-title":"Pharm Res"},{"key":"10.1016\/j.apsb.2020.12.019_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1748-1716.2007.01777.x","article-title":"Comparative study of the effect of luminal hypotonicity on mucosal permeability in rat upper gastrointestinal tract","volume":"193","author":"Pihl","year":"2008","journal-title":"Acta Physiol"},{"key":"10.1016\/j.apsb.2020.12.019_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1152\/jappl.1997.83.1.204","article-title":"Absorption from different intestinal segments during exercise","volume":"83","author":"Lambert","year":"1997","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.apsb.2020.12.019_bib45","doi-asserted-by":"crossref","first-page":"G360","DOI":"10.1152\/ajpgi.00428.2002","article-title":"Hypotonicity-induced increases in duodenal mucosal permeability facilitates adjustment of luminal osmolality","volume":"285","author":"Nylander","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2020.12.019_bib46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1748-1716.2005.01507.x","article-title":"Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine","volume":"186","author":"Nylander","year":"2006","journal-title":"Acta Physiol"},{"key":"10.1016\/j.apsb.2020.12.019_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1748-1716.2012.02411.x","article-title":"The selective cyclooxygenase-2 inhibitor parecoxib markedly improves the ability of the duodenum to regulate luminal hypertonicity in anaesthetized rats","volume":"205","author":"Sedin","year":"2012","journal-title":"Acta Physiol"},{"key":"10.1016\/j.apsb.2020.12.019_bib48","first-page":"36","article-title":"Pharmacology of local anesthetics","volume":"55","author":"Conklin","year":"1987","journal-title":"AANA J (Am Assoc Nurse Anesth)"},{"key":"10.1016\/j.apsb.2020.12.019_bib49","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1053\/gast.2000.18148","article-title":"Permeability of the rat small intestinal epithelium along the villus-crypt axis: effects of glucose transport","volume":"119","author":"Fihn","year":"2000","journal-title":"Gastroenterology"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521000010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:49:11Z","timestamp":1761929351000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521000010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2211383521000010"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2020.12.019","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of paracellular permeation enhancers on intestinal permeability of two peptide drugs, enalaprilat and hexarelin, in rats","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2020.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}